Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innate Pharma SA

2.09
+0.11005.56%
Post-market: 2.05-0.0400-1.91%16:00 EDT
Volume:35.15K
Turnover:73.59K
Market Cap:175.17M
PE:-3.31
High:2.14
Open:2.03
Low:2.02
Close:1.98
Loading ...

Number of Shares and Voting Rights of Innate Pharma as of April 25, 2025

Business Wire
·
Yesterday

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

Benzinga
·
24 Apr

Innate Pharma Price Target Cut to $11.00/Share From $11.50 by HC Wainwright & Co.

Dow Jones
·
24 Apr

Innate Pharma, Sanofi Finalize Investment

MT Newswires Live
·
24 Apr

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Trump Softens Stance on Powell, Tariffs

MT Newswires Live
·
23 Apr

Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement

MT Newswires Live
·
23 Apr

Innate Pharma to Propose Corporate Governance Structure Change

MT Newswires Live
·
16 Apr

Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum

Business Wire
·
03 Apr

European Penny Stocks To Watch In March 2025

Simply Wall St.
·
31 Mar

Innate Pharma Price Target Maintained With a $11.50/Share by HC Wainwright & Co.

Dow Jones
·
28 Mar

Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ...

GuruFocus.com
·
28 Mar

Innate Pharma FY EPS $(0.65) Down From $(0.10) YoY, Sales $22.54M Down From $66.35M YoY

Benzinga
·
27 Mar

Press Release: Innate Pharma Reports Full Year 2024 Financial Results and Business Update

Dow Jones
·
27 Mar

Press Release: Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results

Dow Jones
·
20 Mar

Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference

Business Wire
·
27 Feb

Innate Pharma Shares Rise After Breakthrough Therapy Designation for Lacutamab

Dow Jones
·
18 Feb

US Equity Futures Rise Pre-Bell as Wall Street Kicks Off Holiday-Shortened Trading Week

MT Newswires Live
·
18 Feb

Top Premarket Gainers

MT Newswires Live
·
18 Feb

Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome

Business Wire
·
17 Feb

Innate Pharma SA (IPHYF) Gets a Hold from Kepler Capital

TIPRANKS
·
14 Feb